Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesIdentifying The Potential For Tamoxifen Resistance In Patients
ScienceDaily, 06/26/09
Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death. Researchers have uncovered a protein profile that may accurately predict whether a cancer will be tamoxifen resistant.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Be Overweight And Live Longer, German Study Suggests
ScienceDaily, 10/19/09
Even Low Alcohol Consumption Has A Negative Impact On Overall Health, Researchers Argue
ScienceDaily, 10/26/09
Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
EurekAlert, 11/03/09
Sponsor
Article Search
Sponsor